Hydrogel-encapsulated extracellular vesicles for the regeneration of spinal cord injury

被引:7
|
作者
Nazerian, Yasaman [1 ]
Nazerian, Amirhossein [2 ]
Mohamadi-Jahani, Fereshteh [1 ]
Sodeifi, Parastoo [3 ]
Jafarian, Maryam [1 ]
Javadi, Seyed Amir Hossein [1 ,4 ]
机构
[1] Univ Tehran Med Sci, Neurosci Inst, Brain & Spinal Cord Injury Res Ctr, Tehran, Iran
[2] Iran Univ Med Sci, Sch Med, Tehran, Iran
[3] Islamic Azad Univ Med Sci, Sch Med, Tehran, Iran
[4] Univ Tehran Med Sci, Imam Khomeini Hosp Complex, Dept Neurosurg, Tehran, Iran
关键词
spinal cord injuries; stem cells; cell transplantation; EVS; hydrogel; nerve repair; MESENCHYMAL STEM-CELLS; PROMOTES FUNCTIONAL RECOVERY; NEURAL PROGENITOR; STROMAL CELLS; EXOSOMES; INFLAMMATION; APOPTOSIS; DELIVERY; REPAIR; TRANSPLANTATION;
D O I
10.3389/fnins.2023.1309172
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Spinal cord injury (SCI) is a critical neurological condition that may impair motor, sensory, and autonomous functions. At the cellular level, inflammation, impairment of axonal regeneration, and neuronal death are responsible for SCI-related complications. Regarding the high mortality and morbidity rates associated with SCI, there is a need for effective treatment. Despite advances in SCI repair, an optimal treatment for complete recovery after SCI has not been found so far. Therefore, an effective strategy is needed to promote neuronal regeneration and repair after SCI. In recent years, regenerative treatments have become a potential option for achieving improved functional recovery after SCI by promoting the growth of new neurons, protecting surviving neurons, and preventing additional damage to the spinal cord. Transplantation of cells and cells-derived extracellular vesicles (EVs) can be effective for SCI recovery. However, there are some limitations and challenges related to cell-based strategies. Ethical concerns and limited efficacy due to the low survival rate, immune rejection, and tumor formation are limitations of cell-based therapies. Using EVs is a helpful strategy to overcome these limitations. It should be considered that short half-life, poor accumulation, rapid clearance, and difficulty in targeting specific tissues are limitations of EVs-based therapies. Hydrogel-encapsulated exosomes have overcome these limitations by enhancing the efficacy of exosomes through maintaining their bioactivity, protecting EVs from rapid clearance, and facilitating the sustained release of EVs at the target site. These hydrogel-encapsulated EVs can promote neuroregeneration through improving functional recovery, reducing inflammation, and enhancing neuronal regeneration after SCI. This review aims to provide an overview of the current research status, challenges, and future clinical opportunities of hydrogel-encapsulated EVs in the treatment of SCI.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] An ECM-Mimetic Hydrogel to Promote the Therapeutic Efficacy of Osteoblast-Derived Extracellular Vesicles for Bone Regeneration
    Man, Kenny
    Brunet, Mathieu Y.
    Federici, Angelica S.
    Hoey, David A.
    Cox, Sophie C.
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2022, 10
  • [32] The effects of GelMA hydrogel on nerve repair and regeneration in mice with spinal cord injury
    Zhang, Hongcheng
    Xu, Jinhui
    Saijilafu
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (14)
  • [33] Macrophage Polarization-Based Biomaterials for Repairing Spinal Cord Injury
    Luo, Junchao
    Hu, Wei
    Gao, Xiang
    Bai, Jinyu
    Sheng, Lei
    Yang, Huilin
    Zhou, Xiao-zhong
    Shi, Qin
    ACS MATERIALS LETTERS, 2024, 6 (12): : 5438 - 5453
  • [34] Controlled extracellular vesicles release from aminoguanidine nanoparticle-loaded polylysine hydrogel for synergistic treatment of spinal cord injury
    Wang, Shaoke
    Wang, Rui
    Chen, Jiangjie
    Yang, Biao
    Shu, Jiawei
    Cheng, Feng
    Tao, Yiqing
    Shi, Kesi
    Wang, Chenggui
    Wang, Jingkai
    Xia, Kaishun
    Zhang, Yuang
    Chen, Qixin
    Liang, Chengzhen
    Tang, Jianbin
    Li, Fangcai
    JOURNAL OF CONTROLLED RELEASE, 2023, 363 : 27 - 42
  • [35] Injectable hydrogel microspheres encapsulating extracellular vesicles derived from melatonin-stimulated NSCs promote neurogenesis and alleviate inflammation in spinal cord injury
    Zeng, Junkai
    Gu, Changjiang
    Zhuang, Yu
    Lin, Kaili
    Xie, Youzhuan
    Chen, Xiongsheng
    CHEMICAL ENGINEERING JOURNAL, 2023, 470
  • [36] Biomimetic synthesis and optimization of extracellular vesicles for bone regeneration
    Song, Xinyu
    Xu, Ling
    Zhang, Wenjie
    JOURNAL OF CONTROLLED RELEASE, 2023, 355 : 18 - 41
  • [37] Intrathecal Injection of Autologous Mesenchymal Stem-Cell-Derived Extracellular Vesicles in Spinal Cord Injury: A Feasibility Study in Pigs
    Shulman, Ilya
    Ageeva, Tatyana
    Kostennikov, Alexander
    Ogurcov, Sergei
    Tazetdinova, Leysan
    Kabdesh, Ilyas
    Rogozhin, Alexander
    Ganiev, Ilnur
    Rizvanov, Albert
    Mukhamedshina, Yana
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (09)
  • [38] Extracellular Vesicles as Therapeutics for Brain Injury and Disease
    Upadhya, Dinesh
    Shetty, Ashok K.
    CURRENT PHARMACEUTICAL DESIGN, 2019, 25 (33) : 3500 - 3505
  • [39] High-Performance Hydrogel-Encapsulated Engineered Exosomes for Supporting Endoplasmic Reticulum Homeostasis and Boosting Diabetic Bone Regeneration
    Liu, Yulan
    Lin, Sihan
    Xu, Zeqian
    Wu, Yuqiong
    Wang, Guifang
    Yang, Guangzheng
    Cao, Lingyan
    Chang, Haishuang
    Zhou, Mingliang
    Jiang, Xinquan
    ADVANCED SCIENCE, 2024, 11 (17)
  • [40] Thermosensitive heparin-poloxamer hydrogel encapsulated bFGF and NGF to treat spinal cord injury
    Hu, Xiaoli
    Li, Rui
    Wu, Yanqing
    Li, Yi
    Zhong, Xingfeng
    Zhang, Guanyinsheng
    Kang, Yanmin
    Liu, Shuhua
    Xie, Ling
    Ye, Junming
    Xiao, Jian
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (14) : 8166 - 8178